{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,18]],"date-time":"2026-07-18T11:08:08Z","timestamp":1784372888633,"version":"3.55.0"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2020,3,23]],"date-time":"2020-03-23T00:00:00Z","timestamp":1584921600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,3,23]],"date-time":"2020-03-23T00:00:00Z","timestamp":1584921600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Ensign Endowment for Gynecologic Cancer Research"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Gynecol Obstet"],"published-print":{"date-parts":[[2020,5]]},"DOI":"10.1007\/s00404-020-05508-3","type":"journal-article","created":{"date-parts":[[2020,3,23]],"date-time":"2020-03-23T16:05:01Z","timestamp":1584979501000},"page":"1235-1245","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Temporal trends of subsequent breast cancer among women with ovarian cancer: a population-based study"],"prefix":"10.1007","volume":"301","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6232-8701","authenticated-orcid":false,"given":"Koji","family":"Matsuo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel S.","family":"Mandelbaum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroko","family":"Machida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kosuke","family":"Yoshihara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinya","family":"Matsuzaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maximilian","family":"Klar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franco M.","family":"Muggia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lynda D.","family":"Roman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason D.","family":"Wright","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,3,23]]},"reference":[{"key":"5508_CR1","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21442","volume":"68","author":"RL Siegel","year":"2019","unstructured":"Siegel RL, Miller KD, Jemal A. Cancer statistics, 2019. CA Cancer J Clin 2019;69:7\u201334.","journal-title":"CA Cancer J Clin"},{"key":"5508_CR2","doi-asserted-by":"crossref","unstructured":"Practice Bulletin No 182: Hereditary Breast and Ovarian Cancer Syndrome (2017) Obstet Gynecol 130:e110\u2013e126.","DOI":"10.1097\/AOG.0000000000002296"},{"key":"5508_CR3","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.ygyno.2014.10.029","volume":"136","author":"E Molina-Montes","year":"2015","unstructured":"Molina-Montes E, Requena M, Sanchez-Cantalejo E, Fernandez MF, Arroyo-Morales M, Espin J, Arrebola JP, Sanchez MJ (2015) Risk of second cancers cancer after a first primary breast cancer: a systematic review and meta-analysis. Gynecol Oncol 136:158\u2013171","journal-title":"Gynecol Oncol"},{"key":"5508_CR4","doi-asserted-by":"publisher","first-page":"2285","DOI":"10.1002\/ijc.21651","volume":"118","author":"L Mellemkjaer","year":"2006","unstructured":"Mellemkjaer L, Friis S, Olsen JH, Scelo G, Hemminki K, Tracey E, Andersen A, Brewster DH, Pukkala E, McBride ML, Kliewer EV, Tonita JM, Kee-Seng C, Pompe-Kirn V, Martos C, Jonasson JG, Boffetta P, Brennan P (2006) Risk of second cancer among women with breast cancer. Int J Cancer 118:2285\u20132292","journal-title":"Int J Cancer"},{"key":"5508_CR5","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1038\/sj.bjc.6604241","volume":"98","author":"YM Kirova","year":"2008","unstructured":"Kirova YM, De Rycke Y, Gambotti L, Pierga JY, Asselain B, Fourquet A (2008) Second malignancies after breast cancer: the impact of different treatment modalities. Br J Cancer 98:870\u2013874","journal-title":"Br J Cancer"},{"key":"5508_CR6","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1093\/aje\/152.6.528","volume":"152","author":"V McGuire","year":"2000","unstructured":"McGuire V, Whittemore AS, Norris R, Oakley-Girvan I (2000) Survival in epithelial ovarian cancer patients with prior breast cancer. Am J Epidemiol 152:528\u2013532","journal-title":"Am J Epidemiol"},{"key":"5508_CR7","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1007\/s12672-018-0330-0","volume":"9","author":"Z Li","year":"2018","unstructured":"Li Z, Wu Q, Song J, Zhang Y, Zhu S, Sun S (2018) Risk of second primary female genital malignancies in women with breast cancer: a SEER Analysis. Horm Cancer 9:197\u2013204","journal-title":"Horm Cancer"},{"key":"5508_CR8","first-page":"995","volume":"10","author":"HI Hall","year":"2001","unstructured":"Hall HI, Jamison P, Weir HK (2001) Second primary ovarian cancer among women diagnosed previously with cancer. Cancer Epidemiol Biomarkers Prev 10:995\u2013999","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"5508_CR9","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1200\/JCO.2012.43.2757","volume":"31","author":"SJ Schonfeld","year":"2013","unstructured":"Schonfeld SJ, de Gonzalez BA, Visvanathan K, Pfeiffer RM, Anderson WF (2013) Declining second primary ovarian cancer after first primary breast cancer. J Clin Oncol 31:738\u2013743","journal-title":"J Clin Oncol"},{"key":"5508_CR10","doi-asserted-by":"publisher","first-page":"1344","DOI":"10.1002\/cncr.27842","volume":"119","author":"SM Domchek","year":"2013","unstructured":"Domchek SM, Jhaveri K, Patil S, Stopfer JE, Hudis C, Powers J, Stadler Z, Goldstein L, Kauff N, Khasraw M, Offit K, Nathanson KL, Robson M (2013) Risk of metachronous breast cancer after BRCA mutation-associated ovarian cancer. Cancer 119:1344\u20131348","journal-title":"Cancer"},{"key":"5508_CR11","doi-asserted-by":"publisher","first-page":"1306","DOI":"10.1001\/jamasurg.2014.1081","volume":"149","author":"A Gangi","year":"2014","unstructured":"Gangi A, Cass I, Paik D, Barmparas G, Karlan B, Dang C, Li A, Walsh C, Rimel BJ, Amersi FF (2014) Breast cancer following ovarian cancer in BRCA mutation carriers. JAMA Surg 149:1306\u20131313","journal-title":"JAMA Surg"},{"key":"5508_CR12","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1002\/cncr.27839","volume":"119","author":"PM Vencken","year":"2013","unstructured":"Vencken PM, Kriege M, Hooning M, Menke-Pluymers MB, Heemskerk-Gerritsen BA, van Doorn LC, Collee MM, Jager A, van Montfort C, Burger CW, Seynaeve C (2013) The risk of primary and contralateral breast cancer after ovarian cancer in BRCA1\/BRCA2 mutation carriers: Implications for counseling. Cancer 119:955\u2013962","journal-title":"Cancer"},{"key":"5508_CR13","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1016\/j.ygyno.2017.02.032","volume":"145","author":"J McGee","year":"2017","unstructured":"McGee J, Giannakeas V, Karlan B, Lubinski J, Gronwald J, Rosen B, McLaughlin J, Risch H, Sun P, Foulkes WD, Neuhausen SL, Kotsopoulos J, Narod SA (2017) Risk of breast cancer after a diagnosis of ovarian cancer in BRCA mutation carriers: Is preventive mastectomy warranted? Gynecol Oncol 145:346\u2013351","journal-title":"Gynecol Oncol"},{"key":"5508_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/01.coc.0000231364.89294.13","volume":"30","author":"MI Hunter","year":"2007","unstructured":"Hunter MI, Ziogas A, Flores F, Brewster WR (2007) Epithelial ovarian cancer and low malignant potential (LMP) tumors associated with a lower incidence of second primary breast cancer. Am J Clin Oncol 30:1\u20137","journal-title":"Am J Clin Oncol"},{"key":"5508_CR15","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1038\/gim.2017.118","volume":"20","author":"Z Chen","year":"2018","unstructured":"Chen Z, Kolor K, Grosse SD, Rodriguez JL, Lynch JA, Green RF, Dotson WD, Bowen MS, Khoury MJ (2018) Trends in utilization and costs of BRCA testing among women aged 18\u201364 years in the United States, 2003\u20132014. Genet Med 20:428\u2013434","journal-title":"Genet Med"},{"key":"5508_CR16","unstructured":"Health, United States (2016) Centers for Disease Control and Prevention. https:\/\/www.cdc.gov\/nchs\/data\/hus\/hus16.pdf#053. Accessed 30 May 2019"},{"key":"5508_CR17","unstructured":"An Aging World: 2015. International Population Reports. United States Census Bureau. https:\/\/www.census.gov\/content\/dam\/Census\/library\/publications\/2016\/demo\/p95-16-1.pdf. Accessed 30 May 2019"},{"key":"5508_CR18","unstructured":"The Surveillance, Epidemiology, and End Results (SEER) Program of the National Cancer Institute, https:\/\/seer.cancer.gov\/. Accessed 30 May 2019"},{"key":"5508_CR19","unstructured":"National Cancer Registrars Association. https:\/\/www.ncra-usa.org\/i4a\/pages\/index.cfm?pageid=1%3e. Accessed 30 May 2019"},{"key":"5508_CR20","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1097\/AOG.0000000000002142","volume":"130","author":"K Matsuo","year":"2017","unstructured":"Matsuo K, Machida H, Stone RL, Soliman PT, Thaker PH, Roman LD, Wright JD (2017) Risk of subsequent ovarian cancer after ovarian conservation in young women with stage I endometrioid endometrial cancer. Obstet Gynecol 130:403\u2013410","journal-title":"Obstet Gynecol"},{"key":"5508_CR21","doi-asserted-by":"crossref","first-page":"28757","DOI":"10.18632\/oncotarget.25550","volume":"9","author":"K Matsuo","year":"2018","unstructured":"Matsuo K, Machida H, Blake EA, Holman LL, Rimel BJ, Roman LD, Wright JD (2018) Trends and outcomes of women with synchronous endometrial and ovarian cancer. Oncotarget 9:28757\u201328771","journal-title":"Oncotarget"},{"key":"5508_CR22","unstructured":"Italian Cancer Figures (2014) Report 2013: multiple tumours. Epidemiol Prev 37:1\u2013152"},{"key":"5508_CR23","doi-asserted-by":"publisher","first-page":"3087","DOI":"10.1002\/cncr.26618","volume":"118","author":"DC Bodurka","year":"2012","unstructured":"Bodurka DC, Deavers MT, Tian C, Sun CC, Malpica A, Coleman RL, Lu KH, Sood AK, Birrer MJ, Ozols R, Baergen R, Emerson RE, Steinhoff M, Behmaram B, Rasty G, Gershenson DM (2012) Reclassification of serous ovarian carcinoma by a 2-tier system: a Gynecologic Oncology Group Study. Cancer 118:3087\u20133094","journal-title":"Cancer"},{"key":"5508_CR24","volume-title":"AJCC cancer staging manual","year":"2010","unstructured":"Edge SB, Byrd DR, Compton CC, Fritz AG, Greene FL, Trotti A (eds) (2010) AJCC cancer staging manual, 7th edn. Springer, New York","edition":"7"},{"key":"5508_CR25","unstructured":"National Death Index. https:\/\/www.cdc.gov\/nchs\/ndi\/. Accessed 30 May 2019"},{"key":"5508_CR26","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1002\/(SICI)1097-0258(20000215)19:3<335::AID-SIM336>3.0.CO;2-Z","volume":"19","author":"HJ Kim","year":"2000","unstructured":"Kim HJ, Fay MP, Feuer EJ, Midthune DN (2000) Permutation tests for joinpoint regression with applications to cancer rates. Stat Med 19:335\u2013351","journal-title":"Stat Med"},{"key":"5508_CR27","unstructured":"Cancer stat facts. National Cancer Institute Surveillance Epidemiology End Result Program https:\/\/seer.cancer.gov\/statfacts\/. Accessed 30 May 2019"},{"key":"5508_CR28","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.1016\/j.ejca.2008.11.030","volume":"45","author":"S Rosso","year":"2009","unstructured":"Rosso S, De Angelis R, Ciccolallo L, Carrani E, Soerjomataram I, Grande E, Zigon G, Brenner H (2009) Multiple tumours in survival estimates. Eur J Cancer 45:1080\u20131094","journal-title":"Eur J Cancer"},{"key":"5508_CR29","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1136\/bmj.39335.541782.AD","volume":"335","author":"E von Elm","year":"2007","unstructured":"von Elm E, Altman DG, Egger M, Pocock SJ, Gotzsche PC, Vandenbroucke JP (2007) Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. BMJ 335:806\u2013808","journal-title":"BMJ"},{"key":"5508_CR30","unstructured":"Cancer stat facts: female breast cancer. National Cancer Institute, Surveillance, Epidemiology, and End Results Program. https:\/\/seer.cancer.gov\/statfacts\/html\/breast.html. Accessed 30 May 2019"},{"key":"5508_CR31","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.1002\/ijc.29386","volume":"137","author":"J Kotsopoulos","year":"2015","unstructured":"Kotsopoulos J, Lubinski J, Gronwald J, Cybulski C, Demsky R, Neuhausen SL, Kim-Sing C, Tung N, Friedman S, Senter L, Weitzel J, Karlan B, Moller P, Sun P, Narod SA (2015) Factors influencing ovulation and the risk of ovarian cancer in BRCA1 and BRCA2 mutation carriers. Int J Cancer 137:1136\u20131146","journal-title":"Int J Cancer"},{"issue":"199","key":"5508_CR32","first-page":"204","volume":"21","author":"H Primas","year":"2012","unstructured":"Primas H, Kroiss R, Kalteis K, Rappaport C, Muhr D, Primas C, Kubista E, Horvat R, Oefner P, Singer WC, The Austrian Hereditary B, Ovarian Cancer Group T (2012) Impact of lifestyle factors on preneoplastic changes in prophylactic oophorectomies of BRCA mutation carriers. Eur J Cancer Prev 21(199):204","journal-title":"Eur J Cancer Prev"},{"key":"5508_CR33","doi-asserted-by":"publisher","first-page":"7491","DOI":"10.1200\/JCO.2004.00.7138","volume":"23","author":"A Eisen","year":"2005","unstructured":"Eisen A, Lubinski J, Klijn J, Moller P, Lynch HT, Offit K, Weber B, Rebbeck T, Neuhausen SL, Ghadirian P, Foulkes WD, Gershoni-Baruch R, Friedman E, Rennert G, Wagner T, Isaacs C, Kim-Sing C, Ainsworth P, Sun P, Narod SA (2005) Breast cancer risk following bilateral oophorectomy in BRCA1 and BRCA2 mutation carriers: an international case-control study. J Clin Oncol 23:7491\u20137496","journal-title":"J Clin Oncol"},{"key":"5508_CR34","doi-asserted-by":"publisher","first-page":"2108","DOI":"10.1002\/cncr.29321","volume":"121","author":"JL Walker","year":"2015","unstructured":"Walker JL, Powell CB, Chen LM, Carter J, Bae Jump VL, Parker LP, Borowsky ME, Gibb RK (2015) Society of Gynecologic Oncology recommendations for the prevention of ovarian cancer. Cancer 121:2108\u20132120","journal-title":"Cancer"},{"key":"5508_CR35","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1038\/378789a0","volume":"378","author":"R Wooster","year":"1995","unstructured":"Wooster R, Bignell G, Lancaster J, Swift S, Seal S, Mangion J, Collins N, Gregory S, Gumbs C, Micklem G (1995) Identification of the breast cancer susceptibility gene BRCA2. Nature 378:789\u2013792","journal-title":"Nature"},{"key":"5508_CR36","doi-asserted-by":"publisher","first-page":"1684","DOI":"10.1126\/science.2270482","volume":"250","author":"JM Hall","year":"1990","unstructured":"Hall JM, Lee MK, Newman B, Morrow JE, Anderson LA, Huey B, King MC (1990) Linkage of early-onset familial breast cancer to chromosome 17q21. Science 250:1684\u20131689","journal-title":"Science"},{"key":"5508_CR37","doi-asserted-by":"publisher","first-page":"2260","DOI":"10.1001\/jama.283.17.2260","volume":"283","author":"J Boyd","year":"2000","unstructured":"Boyd J, Sonoda Y, Federici MG, Bogomolniy F, Rhei E, Maresco DL, Saigo PE, Almadrones LA, Barakat RR, Brown CL, Chi DS, Curtin JP, Poynor EA, Hoskins WJ (2000) Clinicopathologic features of BRCA-linked and sporadic ovarian cancer. JAMA 283:2260\u20132265","journal-title":"JAMA"},{"key":"5508_CR38","doi-asserted-by":"crossref","unstructured":"Matsuo K, Mandelbaum RS, Machida H, Yoshihara K, Muggia FM, Roman LD, Wright JD (2019) Decreasing secondary primary uterine cancer after breast cancer: a population-based analysis. Gynecol Oncol (In Press)","DOI":"10.1016\/j.ygyno.2019.05.014"},{"key":"5508_CR39","doi-asserted-by":"publisher","first-page":"714","DOI":"10.3390\/jcm8050714","volume":"8","author":"K Matsuo","year":"2019","unstructured":"Matsuo K, Mandelbaum RS, Machida H, Yoshihara K, Muggia FM, Roman LD, Wright JD (2019) Decreasing trends of secondary primary colorectal cancer among women with uterine cancer: a population-based analysis. J Clin Med 8:714","journal-title":"J Clin Med"}],"container-title":["Archives of Gynecology and Obstetrics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00404-020-05508-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00404-020-05508-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00404-020-05508-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,23]],"date-time":"2021-03-23T00:29:32Z","timestamp":1616459372000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00404-020-05508-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3,23]]},"references-count":39,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2020,5]]}},"alternative-id":["5508"],"URL":"https:\/\/doi.org\/10.1007\/s00404-020-05508-3","relation":{},"ISSN":["0932-0067","1432-0711"],"issn-type":[{"value":"0932-0067","type":"print"},{"value":"1432-0711","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,3,23]]},"assertion":[{"value":"1 October 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 March 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 March 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"Consultant, Clovis Oncology and Tesaro, research funding, Merck (JDW); consultant, Quantgene (LDR); honorarium, Chugai, textbook editorial expense, Springer, and investigator meeting attendance expense, VBL therapeutics (KM); none for others.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This article used publicly available deidentified data and does not contain any studies with human participants performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Not applicable for this study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}